Evidation Insights from 165,000 People Show Continued Growth Potential Amid Uneven Adoption in the GLP-1 Market
July 2, 2026 Among 119,000 surveyed individuals actively trying to lose weight, 24% had ever used prescription medication for weight management and 15% had ever used a GLP-1, suggesting significant room for continued market growth as adoption varies by age, gender, and income.
ISPOR 2026 Recap: Understanding Health Between Visits
May 27, 2026 Evidation’s research at ISPOR 2026 highlighted the growing need for direct, longitudinal patient data to better understand real-world outcomes.
Creating a Complete View of Dermatology Care to Strengthen Brand and Portfolio Decisions to Drive Competitive Advantage
April 22, 2026 Explore how longitudinal, multimodal real-world data collected through direct connections to individuals can sharpen brand positioning, clarify unmet need, and strengthen lifecycle and access strategy in competitive dermatology markets.
March 26, 2026 New cohort is designed to address gaps in understanding treatment journeys across the full continuum of care. Insights show that consumer health products play a critical part in how individuals understand and manage their skin conditions.
Enabling Next-Generation AI in Autoimmune R&D
February 3, 2026 Explore how longitudinal, temporally relevant, multimodal data collected through direct connections with individuals can help unlock new opportunities across early R&D for immune-mediated diseases.
Better data, better outcomes: Weight management
September 16, 2024 Survey + wearable data from Evidation members about their weight management experiences have highlighted real-world priorities, challenges, and opportunities in this space.
REVEAL, a prospective, observational study
August 9, 2024 Evidation and partners aimed to examine the impact of paroxysmal nocturnal hemoglobinuria (PNH) and its treatment on patients’ daily lives by combining patient-reported outcomes with wearable technology.
Equitable research drives equitable health care: The power of patient-reported outcomes (PROs)
July 30, 2024 Learn how integrating participant-reported outcome (PRO) data with social determinants of health (SDOH) can identify and address disparities in access to care, treatment outcomes, and satisfaction with health care.